Answers are grounded in this paper and cite their sources.
Data on the effectiveness of ceftazidime-avibactam (CAZ-AVI) in critically ill, mechanically ventilated patients are limited. The present retrospective observational cohort study, which was conducted in two general intensive care units (ICUs) in central Greece, compared critically ill, mechanically ventilated patients suffering from carbapenem-resistant Enterobacteriaceae (CRE) infections receiving CAZ-AVI to patients who received appropriate available antibiotic therapy.
No takes yet. Share an insight, caveat, or question.
Tsolaki et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: